Logo image of CPRI

CAPRI HOLDINGS LTD (CPRI) Stock Fundamental Analysis

USA - NYSE:CPRI - VGG1890L1076 - Common Stock

21.67 USD
+1.22 (+5.97%)
Last: 9/15/2025, 8:04:00 PM
21.26 USD
-0.41 (-1.89%)
After Hours: 9/15/2025, 8:04:00 PM
Fundamental Rating

3

CPRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 49 industry peers in the Textiles, Apparel & Luxury Goods industry. CPRI may be in some trouble as it scores bad on both profitability and health. CPRI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CPRI had positive earnings in the past year.
In the past year CPRI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CPRI reported negative net income in multiple years.
CPRI had a positive operating cash flow in each of the past 5 years.
CPRI Yearly Net Income VS EBIT VS OCF VS FCFCPRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

CPRI's Return On Assets of -20.39% is on the low side compared to the rest of the industry. CPRI is outperformed by 87.76% of its industry peers.
The Return On Invested Capital of CPRI (1.48%) is worse than 81.63% of its industry peers.
CPRI had an Average Return On Invested Capital over the past 3 years of 5.93%. This is significantly below the industry average of 12.08%.
The last Return On Invested Capital (1.48%) for CPRI is well below the 3 year average (5.93%), which needs to be investigated, but indicates that CPRI had better years and this may not be a problem.
Industry RankSector Rank
ROA -20.39%
ROE N/A
ROIC 1.48%
ROA(3y)-5.88%
ROA(5y)-1.5%
ROE(3y)-100.73%
ROE(5y)-54.59%
ROIC(3y)5.93%
ROIC(5y)7.29%
CPRI Yearly ROA, ROE, ROICCPRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

CPRI has a worse Operating Margin (1.82%) than 77.55% of its industry peers.
In the last couple of years the Operating Margin of CPRI has declined.
With an excellent Gross Margin value of 63.26%, CPRI belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
CPRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.82%
PM (TTM) N/A
GM 63.26%
OM growth 3Y-59.47%
OM growth 5Y-34.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y1.54%
CPRI Yearly Profit, Operating, Gross MarginsCPRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CPRI is destroying value.
Compared to 1 year ago, CPRI has more shares outstanding
Compared to 5 years ago, CPRI has less shares outstanding
The debt/assets ratio for CPRI is higher compared to a year ago.
CPRI Yearly Shares OutstandingCPRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CPRI Yearly Total Debt VS Total AssetsCPRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.24 indicates that CPRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
CPRI has a worse Altman-Z score (2.24) than 69.39% of its industry peers.
CPRI has a debt to FCF ratio of 18.16. This is a negative value and a sign of low solvency as CPRI would need 18.16 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 18.16, CPRI is in line with its industry, outperforming 40.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 18.16
Altman-Z 2.24
ROIC/WACC0.17
WACC8.77%
CPRI Yearly LT Debt VS Equity VS FCFCPRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 1.17 indicates that CPRI should not have too much problems paying its short term obligations.
The Current ratio of CPRI (1.17) is worse than 87.76% of its industry peers.
CPRI has a Quick Ratio of 1.17. This is a bad value and indicates that CPRI is not financially healthy enough and could expect problems in meeting its short term obligations.
CPRI has a worse Quick ratio (0.61) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.61
CPRI Yearly Current Assets VS Current LiabilitesCPRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

3

3. Growth

3.1 Past

CPRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.41%.
CPRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -26.36% yearly.
Looking at the last year, CPRI shows a very negative growth in Revenue. The Revenue has decreased by -16.69% in the last year.
Measured over the past years, CPRI shows a decrease in Revenue. The Revenue has been decreasing by -4.36% on average per year.
EPS 1Y (TTM)-53.41%
EPS 3Y-48.61%
EPS 5Y-26.36%
EPS Q2Q%1150%
Revenue 1Y (TTM)-16.69%
Revenue growth 3Y-7.73%
Revenue growth 5Y-4.36%
Sales Q2Q%-25.3%

3.2 Future

Based on estimates for the next years, CPRI will show a very strong growth in Earnings Per Share. The EPS will grow by 46.93% on average per year.
Based on estimates for the next years, CPRI will show a decrease in Revenue. The Revenue will decrease by -2.52% on average per year.
EPS Next Y61.5%
EPS Next 2Y43.53%
EPS Next 3Y40.35%
EPS Next 5Y46.93%
Revenue Next Year-20.93%
Revenue Next 2Y-9.43%
Revenue Next 3Y-5.98%
Revenue Next 5Y-2.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CPRI Yearly Revenue VS EstimatesCPRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
CPRI Yearly EPS VS EstimatesCPRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.67, the valuation of CPRI can be described as correct.
Based on the Price/Earnings ratio, CPRI is valued a bit cheaper than 63.27% of the companies in the same industry.
When comparing the Price/Earnings ratio of CPRI to the average of the S&P500 Index (27.27), we can say CPRI is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 12.52, the valuation of CPRI can be described as correct.
79.59% of the companies in the same industry are more expensive than CPRI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.77, CPRI is valued a bit cheaper.
Industry RankSector Rank
PE 16.67
Fwd PE 12.52
CPRI Price Earnings VS Forward Price EarningsCPRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPRI indicates a slightly more expensive valuation: CPRI is more expensive than 65.31% of the companies listed in the same industry.
CPRI's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 28.04
EV/EBITDA 15.78
CPRI Per share dataCPRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CPRI's earnings are expected to grow with 40.35% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y43.53%
EPS Next 3Y40.35%

0

5. Dividend

5.1 Amount

No dividends for CPRI!.
Industry RankSector Rank
Dividend Yield N/A

CAPRI HOLDINGS LTD

NYSE:CPRI (9/15/2025, 8:04:00 PM)

After market: 21.26 -0.41 (-1.89%)

21.67

+1.22 (+5.97%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners97.68%
Inst Owner Change2.31%
Ins Owners2.24%
Ins Owner Change4.35%
Market Cap2.58B
Analysts68.42
Price Target25.61 (18.18%)
Short Float %10%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)87.12%
Min EPS beat(2)-102.84%
Max EPS beat(2)277.07%
EPS beat(4)1
Avg EPS beat(4)31.34%
Min EPS beat(4)-102.84%
Max EPS beat(4)277.07%
EPS beat(8)1
Avg EPS beat(8)-7.86%
EPS beat(12)4
Avg EPS beat(12)-5.36%
EPS beat(16)8
Avg EPS beat(16)3.29%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-1.48%
Max Revenue beat(2)2.88%
Revenue beat(4)1
Avg Revenue beat(4)-2.62%
Min Revenue beat(4)-10.23%
Max Revenue beat(4)2.88%
Revenue beat(8)1
Avg Revenue beat(8)-4.8%
Revenue beat(12)3
Avg Revenue beat(12)-3.35%
Revenue beat(16)7
Avg Revenue beat(16)-1.58%
PT rev (1m)7.26%
PT rev (3m)4.59%
EPS NQ rev (1m)-32.65%
EPS NQ rev (3m)-53.88%
EPS NY rev (1m)2.14%
EPS NY rev (3m)29.31%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-16.56%
Revenue NY rev (1m)1.43%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 16.67
Fwd PE 12.52
P/S 0.62
P/FCF 28.04
P/OCF 13.58
P/B N/A
P/tB N/A
EV/EBITDA 15.78
EPS(TTM)1.3
EY6%
EPS(NY)1.73
Fwd EY7.99%
FCF(TTM)0.77
FCFY3.57%
OCF(TTM)1.6
OCFY7.36%
SpS35.04
BVpS-0.14
TBVpS-6.85
PEG (NY)0.27
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.39%
ROE N/A
ROCE 1.87%
ROIC 1.48%
ROICexc 1.52%
ROICexgc 1.91%
OM 1.82%
PM (TTM) N/A
GM 63.26%
FCFM 2.21%
ROA(3y)-5.88%
ROA(5y)-1.5%
ROE(3y)-100.73%
ROE(5y)-54.59%
ROIC(3y)5.93%
ROIC(5y)7.29%
ROICexc(3y)6.19%
ROICexc(5y)7.57%
ROICexgc(3y)13.19%
ROICexgc(5y)17.21%
ROCE(3y)7.5%
ROCE(5y)9.23%
ROICexcg growth 3Y-59.18%
ROICexcg growth 5Y-34.44%
ROICexc growth 3Y-56.73%
ROICexc growth 5Y-31.62%
OM growth 3Y-59.47%
OM growth 5Y-34.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y1.54%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 18.16
Debt/EBITDA 6.55
Cap/Depr 55.68%
Cap/Sales 2.35%
Interest Coverage 0.9
Cash Conversion 75.4%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.61
Altman-Z 2.24
F-Score5
WACC8.77%
ROIC/WACC0.17
Cap/Depr(3y)97.7%
Cap/Depr(5y)82.67%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.41%
EPS 3Y-48.61%
EPS 5Y-26.36%
EPS Q2Q%1150%
EPS Next Y61.5%
EPS Next 2Y43.53%
EPS Next 3Y40.35%
EPS Next 5Y46.93%
Revenue 1Y (TTM)-16.69%
Revenue growth 3Y-7.73%
Revenue growth 5Y-4.36%
Sales Q2Q%-25.3%
Revenue Next Year-20.93%
Revenue Next 2Y-9.43%
Revenue Next 3Y-5.98%
Revenue Next 5Y-2.52%
EBIT growth 1Y-73.05%
EBIT growth 3Y-62.6%
EBIT growth 5Y-37.79%
EBIT Next Year161.09%
EBIT Next 3Y59.51%
EBIT Next 5Y48.66%
FCF growth 1Y-78.8%
FCF growth 3Y-35.61%
FCF growth 5Y-24.79%
OCF growth 1Y-71.81%
OCF growth 3Y-26.37%
OCF growth 5Y-20.03%